BRD4 belongs to BET family member and preclinical studies with BRD4 inhibitors demonstrate the suppression of MYC expression in MYC-driven Burkitt’s lymphoma cell lines (127). This evidence concerns the gene BRD4 and Burkitt lymphoma.